Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients

Infect Dis (Lond). 2022 Jun;54(6):460-463. doi: 10.1080/23744235.2022.2033312. Epub 2022 Feb 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Viral
  • COVID-19*
  • Cohort Studies
  • Humans
  • Immunoglobulin G
  • Pakistan / epidemiology

Substances

  • Antibodies, Viral
  • Immunoglobulin G